Avricore Health (AVCRF) Common Equity (2014 - 2025)

Avricore Health (AVCRF) has 12 years of Common Equity data on file, last reported at $939833.3 in Q3 2025.

• Common Equity for Q3 2025 came in at $939833.3, down 48.48% year-over-year; the trailing twelve-month figure through Sep 2025 was $939833.3 (down 48.48% YoY), and the FY2025 annual result was $939833.3, changed N/A from the prior year.
• Common Equity eased to $939833.3 in Q3 2025 per AVCRF's latest filing, from $1.2 million in the prior quarter.
• Over five years, Common Equity peaked at $77.1 million in Q3 2021 and troughed at $939833.3 in Q3 2025.
• A 5-year average of $5.9 million and a median of $1.4 million in 2022 frame the typical range for Common Equity.
• The sharpest annual moves came in 2021 and 2022: Common Equity jumped 413.82% in 2021, then plunged 98.26% in 2022.
• A 5-year view of Common Equity shows it stood at $1.7 million in 2021, then retreated by 16.98% to $1.4 million in 2022, then advanced by 1.98% to $1.5 million in 2023, then declined by 4.55% to $1.4 million in 2024, then tumbled by 33.28% to $939833.3 in 2025.
• Business Quant data shows AVCRF's Common Equity at $939833.3 in Q3 2025, $1.2 million in Q2 2025, and $1.4 million in Q1 2025.